95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-11.91%
Negative revenue growth while RGLD stands at 20.84%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-13.92%
Negative gross profit growth while RGLD is at 30.30%. Joel Greenblatt would examine cost competitiveness or demand decline.
-16.76%
Negative EBIT growth while RGLD is at 51.78%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-16.76%
Negative operating income growth while RGLD is at 51.78%. Joel Greenblatt would press for urgent turnaround measures.
-10.50%
Negative net income growth while RGLD stands at 39.09%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-16.67%
Negative EPS growth while RGLD is at 36.77%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-18.18%
Negative diluted EPS growth while RGLD is at 38.26%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
1.61%
Share count expansion well above RGLD's 1.56%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.64%
Diluted share count expanding well above RGLD's 1.47%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-13.76%
Negative OCF growth while RGLD is at 90.30%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-13.76%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
156.85%
Similar 10Y revenue/share CAGR to RGLD's 169.39%. Walter Schloss might see both firms benefiting from the same long-term demand.
-43.56%
Negative 5Y CAGR while RGLD stands at 165.94%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
90.09%
3Y revenue/share CAGR at 75-90% of RGLD's 108.34%. Bill Ackman would expect new product strategies to close the gap.
No Data
No Data available this quarter, please select a different quarter.
3232.53%
5Y OCF/share CAGR above 1.5x RGLD's 389.17%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
785.71%
3Y OCF/share CAGR above 1.5x RGLD's 189.20%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
No Data
No Data available this quarter, please select a different quarter.
2933.79%
5Y net income/share CAGR above 1.5x RGLD's 910.48%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
658.94%
3Y net income/share CAGR above 1.5x RGLD's 224.04%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
698.75%
10Y equity/share CAGR in line with RGLD's 649.83%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
729.85%
5Y equity/share CAGR 1.25-1.5x RGLD's 662.75%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
1036.77%
3Y equity/share CAGR above 1.5x RGLD's 89.34%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.03%
Firm’s AR is declining while RGLD shows 17.52%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
3.87%
Similar asset growth to RGLD's 4.29%. Walter Schloss finds parallel expansions or investment rates.
2.31%
BV/share growth above 1.5x RGLD's 0.99%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-46.62%
We cut SG&A while RGLD invests at 4.09%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.